Article

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2

2020-07-30

Abstract excerpt

There is currently a lack of biological tools to study the replication cycle and pathogenesis of SARS-CoV-2, the etiological agent of COVID-19. Repurposing the existing tools, including antibodies of SARS-CoV, is an effective way to accelerate the development of therapeutics for COVID-19. Here, we extensively characterized antibodies of the SARS-CoV structural proteins for their cross-reactivity, experimental util...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 277f987e-b01c-513d-8cc3-d05c7b20bfac
DOI: 10.1101/2020.07.30.229377

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2DOI 10.1101/2020.07.30.229377Read

Cross-Reactivity of SARS-CoV Structural Protein Antibodies Against SARS-CoV-2Semantic proximity Read

Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecovirusesSemantic proximity Read

Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecovirusesSemantic proximity Read

Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodiesSemantic proximity Read

Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodiesSemantic proximity Read

A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody.Semantic proximity Read

Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variantsSemantic proximity Read

Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike proteinSemantic proximity Read

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variantsSemantic proximity Read

Cross neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spikeSemantic proximity Read

Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology TestsSemantic proximity Read

Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike TrimerSemantic proximity Read